medigraphic.com

2009, Number 4

<< Back Next >>

Med Sur 2009; 16 (4)

Simbióticos, prebióticos y probióticos en la práctica clínica

Carrillo ER, Acevedo FB

Language: Spanish
References: 78
Page: 172-180
PDF size: 80.19 Kb.


ABSTRACT

Recently the action of the symbiotic, probiotics and prebiotics has been studied. Their effects are intestinal and systemic through immuno- metabolic mechanisms by what they have been studied in cancer, allergies, inflammatory intestinal disease, hepatic cirrhosis, pancreatitis and sepsis. Is for this that probiotics and prebiotics must be considered inside the therapeutic nutritional arsenal. In spite of the fact that the clinical evidence is limited, the trend of the results obtained in different studies is positive in relation to the impact on the evolution of different diseases.
The aim of this work is to analyze the current concepts of probiotics, prebiotics and symbiotic and their utility in the clinical practice.


REFERENCES

  1. Consulta de expertos FAO/OMS sobre evaluación de las propiedades saludables y nutricionales de los probióticos en los alimentos, incluida la leche en polvo con bacterias vivas del ácido láctico. FAO/OMS. 2001.

  2. Allan SJ, Okoko B, Matínez E, Gregorio G, Dans LF. Probiotics for treating infectious diarrehoea. The Cochrane Database of Systematic Reviews 2003; 4: Art No CD003048 pub2, DOI:10.1002/14651858.CD003048.pub2.

  3. Parvez S, Malik K.A, Ah Kang S, Kim H. Probiotics and their fermented food products are beneficial for health. J Applied Microbiol 2006; 100: 1171-85.

  4. Metchnikoff E. Lactic acid as inhibiting intestinal putrefaction. In: The prolongation of life: Optimistic studies. London: W. Heinemman; 1907, p. 161-83.

  5. Lilly DM, Stillwell RH. Probiotics: Growth promoting factors produced by microorganisms. Science 1965; 147: 747-8.

  6. Holzapel WH, Haberer P, Snel J, Schillinger U, Huis int’s Veld JHJ. Overview of gut flora and probiotics. Intl J Food Microbiol 1998; 41: 85-101.

  7. Santosa S, Farnworth E, Jones P. Probiotics and Their Potential Health Claims. Nutrition Reviews 2006; 6: 266-74.

  8. Collins JK, Thornston G, O’Sullivan GO. Selection of probiotics strains for human applications. Int Dairy J 1998; 8: 487-90.

  9. Ouwehand AC. Antimicrobial components from lactic acid bacteria. In: Lactic acid bacteria: microbiology and functional aspects. 2nd. Ed. Salminen S, von Wright A (eds.). New York, USA: Marcel Dekker Inc.; 1998; p. 139-59.

  10. Bengmark S. Synbiotics and the mucosal barrier in critically ill patients. Curr Opin Gastroenterol 2005: 21; 712-16.

  11. Vanderhoof JA, Young RJ. Use of probiotics in childhood gastrointestinal disorders. J Pediatr Gastroenterol Nutr 1998; 27: 323-32.

  12. Nieto A. Prevención primaria de la alergia alimentaria – probióticos– tolerancia oral. An Esp Pediatr 1999; s126: 31-4.

  13. Isolauri E, Majamaa H, Arvola T, Rammala I, Virtanen E, Arvilommi H. Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology 1993; 105: 643-50.

  14. St-Onge MP, Farnworth ER, Jones PJM. Consumption of fermented and nonfermented dairy products: effects on cholesterol concentrations and metabolism. Am J Clin Nutr 2000; 71: 674-81.

  15. Majamaa H, Isolauri E. Probiotics: A novel approach in the management of food allergy. J Allergy Clin Immunol 1997; 99: 179-85.

  16. Barboza JE, Vazquez H, Salcedo R, Bautista M. Probióticos y conservadores naturales en alimentos. Acta Universitaria 2004: 14: 32-8.

  17. Premysl F. Probiotics and prebiotics - renaissance of a therapeutic principle. Cent Eur J Med 2007; 2: 237-70.

  18. Reid G, Zalai C, Gardiner G. Urogenital lactobacilli probiotics, reliability and regulatory issues. J Dairy Sci 2001; 84: 164-9.

  19. Bengmark S, Gil A. Control bioecológico y nutricional de la enfermedad: prebióticos, probióticos y simbióticos. Nutr Hosp 2006; 21: 73-83.

  20. Diplock AT, Agget PJ, Ashwell M, Bornet F, Fern EB, Roberfroid MB. Scientific concepts of functional food in Europe. Consensus document. Br J Nutr 1999; 81: 1-27.

  21. MacFarlane S, MacFarlane GT, Cummings JH. Review article: Prebiotics in the gastrointestinal tract. Aliment Pharmacol Ther 2006; 24: 701-14.

  22. Andersson H, Asp N-G, Bruce A, Roos S, Wadstrom T, World AE. Health effects of probiotics and prebiotics: A literature review on human studies. Scand J Nutr 2001; 45: 58-75.

  23. Olveira G, Gonzalez-Molero I. Probióticos y prebióticos en la práctica clínica. Nutr Hosp 2007; 22: 26-34.

  24. Freestone PP, Haigh RD, Williams PH, et al. Stimlation of bacterial growth by heat-stable, norepinephrine-induced auto-inducers. FEMS Micobiol Lett 1991; 172: 53-60.

  25. Knight DJW, Ala’Aldeen D, Bengmark S, Girling KJ. The effect of synbiotics on gastrointestinal flora in the critically ill. (abstract). Br J Anaesth 2004; 92: 307-8.

  26. Sunit CS, Baranwal A. Probiotic use in the critically ill. Indian J Pediatr 2008; 75: 621-7.

  27. Bengmark S, Martindale R. Prebiotics and Synbiotics in Clinical Medicine. Nutr Clin Pract 2005; 20: 244-61.

  28. Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A. Kazamias P, Eleftheriadis E. Benefits of a Synbiotic Formula (Sybiotic 2000 Forte) in Critically III Trauma Patients: Early Results of a Randomized Controlled Trial. World J Surg 2006; 30: 1848-55.

  29. Rayes N, Hansen S, Seehofed D, et al. Early enteral supply of fiber and Lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition 2002; 18: 609-15.

  30. Spindler-Vesel A, Bengmark S. Volvk I, Cerovic O, Kompan L. Synbiotics, Prebiotics, Glutamine or Peptide in Early Enteral Nutrition: a Randomized Study in Trauma Patients. J Parenter Enteral Nutr 2007; 31: 119-26.

  31. Lirusssi F, Mastropasqua E, Orando S. Orlando R. Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis. Cochrane Database Syst Rev 2007. Issue 1. Art No.: CD005165. DOI:10.1002/14651858.CD005165.pub2 Jan 24;(1):CD005165.

  32. Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut microbiota: effect on minimal hepatic encephalopathy in patients with liver cirrhosis. Hepatology 2004; 39: 1441-9.

  33. Nanji AA, Khettry U, Sadrzadeh SMH. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc Soc Exp Bio Med 1994; 205; 243-47.

  34. Cunningham-Rundles S, Ahrne S, Bengmark S, et al. Probiotics and immune response. Am J Gastroenterol 2000; 95: S22-S25.

  35. De Santis A, Famularo G, De Simone C. Probiotics for the hemodynamic alterations of patients with liver cirrhosis. Am J Gastroenterol 2000; 95: 323-4.

  36. Gorbach SL. Probiotics and gastrointestinal health. Am J Gastroenterol 2000; 95: 2-4.

  37. Guslandi M, Mezzi G, Sorghi M, Testoni PA. Saccharomyces boulardii in maintenance treatment of Crohn’s disease. Dig Dis Sci 2000; 45: 1462-64.

  38. Shanahan F. Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology 2001; 120: 622-35.

  39. Solga SF. Probiotics can treat hepatic encephalopathy. Med Hypotheses 2003; 61: 307-13.

  40. Riordan SM, Skinner N, Nagree A, et al. Peripheral blood mononuclear cell expression of Toll-like receptors and relation to cytokine levels in cirrhosis. Hepatology 2003; 37: 1154-64.

  41. Rayes N, Seehofer D, Hansen S, et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 2002; 74: 123-7.

  42. Rayes N, Seehofer D, Theruvath T, et al. Supply of pre and probiotics reduces bacterial infection rates after liver transplantation –a randomized double– blind trial. Am J Transplant 2005; 5: 125-30.

  43. Pathmakanthan S, Walsh M, Bengmark S, et al. Efficacy and tolerability treating acute distal ulcerative colitis with synbiotic enemas: a pilot trial (abstract). United European Gastroenterology Week, Geneva: 2002.

  44. Olah A, Belagyi T, Issekutz A, Gamal ME, Bengmark S. Randomized clinical trial of specific lactobacillus and fiber supplement to early enteral nutrition in patients with acute pacreatitis. Br J Surg 2002; 89: 1103-07.

  45. Olah A, Belagyi T, Issekutz A, Olgyai G. Combination of early nasojejunal feeding with modern synbiotic therapy in the treatment of severe acute pancreatitis (prospective, randomized, double- blind study). Magy Seb 2005; 58: 173-8.

  46. Capurso G, Marignani M, Piciucchi M, Merola E, Fave GD. Probiotics and severe acute pancreatitis. J Clin Gastroenterol 2008; 42; 148-51.

  47. Lutgendorff F, Nijmeijer R, Sandström P, et al. Probiotics Prevent Intestinal Barrier Dysfunction in Acute Pancreatitis in Rats via Induction of Ileal Mucosal Glutathione Biosynthesis. Plos One 2009; 4: 451-2.

  48. Besselink M, Van Santvoort H, Van der Heijden G, et al. New randomized trial of probiotics in pancreatitis needed? Caution advised. Langenbecks Arch Surg 2009; 394: 191-2.

  49. Hosada M, Hashimoto H, He D, Morita H, Hosono A. Effect of administeration of milk fermented with Lactobacillus acidophilus LA-2 on faecal mutagenicity and microflora an human intestine. J Dairy Sci 1996; 79: 745-9.

  50. Hayatsu H, Hayatsu T. Suppressing effect of Lactobacillus casei administration on the urinary mutagenicity arising from ingestion of fried ground beef in the human. Cancer Lett 1993; 73: 173-9.

  51. Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group Eur Urol 1995; 27: 104-9.

  52. El-Nezami H, Mykkänen H, Kankaanpää P, Salminen S, Ahokas J. Ability of Lactobacillus and Probionibaterium strain to remove aflatoxine B1 from chicken duodenum. J Food Protect 2000; 63: 549-52.

  53. Shackelford LA, Rao DR, Chawan CB, Pulusani SR. Effect of feeding fermented milk on the incidence of chemically induced colon tumors in rats. Nutr Cancer 1983; 5: 159-64.

  54. Reddy BS. Possible mechanisms by which pro- and prebiotics influence colon carcinogenesis and tumor growth. J Nutr 1999; 129: 147-82.

  55. Pierre F, Perrin P, Champ M, Bornet F, Meflah K, Menanteau J. Short-chain fructo-oligosaccharides reduce the occurrence of colon tumors and develop gut-associated lymphoid tissue in Min mice. Cancer Res 1997; 57: 225-8.

  56. Orrhage K, Brismar B, Nord CE. Effect of supplements with Bifidobacterium longum and Lactobacillus acidophilus on the intestinal microbiota during administration of clindamycin. Microb Ecol Health Dis 1994; 7: 17-22.

  57. Friend BA, Shahani KM. Nutritional and therapeutic aspects of lactobacilli. J Appl Nutr 1984: 36: 125-33.

  58. Matsuzaki T, Yamazaki R, Hashimoto S, Yokokura T. The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice. J Dairy Sci 1998; 81: 48-53.

  59. Matsuzaki T, Chin J. Modulating immune responses with probiotic bacteria. Immunol Cell Biol 2000; 78: 67-3.

  60. Madsen K, Cornish A, Soper P, et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001; 121: 580-91.

  61. Chiang BL, Sheih YH, Wang LH, Liao CK, Gill HS. Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization and definition of cellular immune responses. Eur J Clin Nutr 2000; 54: 849-55.

  62. Gill HS, Rutherfurd KJ, Cross ML, Gopal PK. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr 2001; 74: 833-9.

  63. Cross ML, Mortensen RR, Kudsk J, Gill HS. Dietary intake of Lactobacillus rhamnosus HNOO1 enhances production of both Th1 and Th2 cytokines in antigen-primed mice. Med Microbiol Immunol 2002; 191: 49-53.

  64. Fukushima Y, Kawata Y, Hara H, Terada A, Mitsuoka T. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 1998; 42: 39-44.

  65. Perdigon G, Vintini E, Alvarez S, Medina M, Medici M. Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria. J Dairy Sci 1999; 82: 1108-14.

  66. Mack DR, Lebel S. Role of probiotics in the modulation of intestinal infections and inflammation. Curr Opin Gastroenterol 2004; 20: 22-6.

  67. Miettinen M, Lehtonen A, Julkunen I, Matikainen S. Lactobacilli and streptococci activate NF-kappa B and STAT signaling pathways in human macrophages. J Immunol 2000; 164: 3733-40.

  68. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibodysecreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 1992; 32: 141-4.

  69. Meydani SN, Ha WK. Immunologic effects of yogurt. Am J Clin Nutr 2000, 71: 861-72.

  70. Sheil B, McCarthy J, O’Mahony L, et al. Is the mucosal route of administration essential for probiótico function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis. Gut 2004; 53: 694-700.

  71. Ezedam J, van Loveren H. Probiotics: Immunomodulation and Evaluation of Safety and Efficacy. Nutrition Reviews 2006; 64: 1-14.

  72. Chapat L, Chemin K, Dubois B, Bourdet-Sicard R, Kaiserlian D. Lactobacillus casei reduces CD8+ T cell mediated skin inflammation. Eur J Immunol 2004; 34: 2520-8.

  73. Yan F, Polk DB. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem 2002; 277: 50959-65.

  74. Ma D, Forsythe P, Bienenstock J. Live Lactobacillus reuteri is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect Immun 2004; 72: 5308-14.

  75. Madsen K. Probiotics in criticall ill patients. J Clin Gastroenterol 2008; 42: 116-18. Órgano de Difusión de la Sociedad de Médicos Revista de Investigación

  76. Endersby R, Walker J. Jijon H. Probiotic bacteria alternate proinflammatory cytokine secretion and maintain colonic permeability in a murine model of sepsis. Gastroenterology 2003; 124: 477.

  77. Sanders ME, Klaenhammer TR. Invited review: the scientific basis of Lactobacillus acidophilus NCFM functionality as a probiotic. J Dairy Sci 2001; 84: 319-31.

  78. Goldin BR, Gualtieri L, Moore RP. The effect of Lactobacillus GG on the initiation and promotion of dimethylhydrazineinduced intestinal tumors in the rat. Nutr Cancer 1996; 25: 197-204.




2020     |     www.medigraphic.com